[Federal Register Volume 60, Number 70 (Wednesday, April 12, 1995)]
[Notices]
[Pages 18617-18618]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-8919]



-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on January 30, 1995, Ganes 
Chemicals, Inc., Industrial Park Road, Pennsville, New Jersey 08070, 
made application to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                            Drug                               Schedule 
------------------------------------------------------------------------
Methylphenidate (1724)......................................  II        
Amobarbital (2125)..........................................  II        
Pentobarbital (2270)........................................  II        
Secobarbital (2315).........................................  II        
Glutethimide (2550).........................................  II        
Methadone (9250)............................................  II        
Methadone-intermediate (9254)...............................  II        
Dextropropoxyphene, bulk (non-dosage forms) (9273)..........  II        
------------------------------------------------------------------------

    The firm plans to manufacturer the controlled substances for 
distribution as bulk products to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application and may also file a written 
request for a hearing thereon in accordance with 21 CFR 1301.54 and in 
the form prescribed by 21 CFR 1316.47.
    Any such comments, objections, or requests for a hearing may be 
addressed to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, United States Department of 
Justice, Washington, D.C. 20537, Attention: DEA Federal Register 
Representative (CCR), and must be filed no later than May 12, 1995.

    [[Page 18618]] Dated: April 4, 1995.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 95-8919 Filed 4-11-95; 8:45 am]
BILLING CODE 4410-09-M